CytomX Therapeutics Announces Preclinical Data from Anti-CTLA-4 Probody Therapeutic Programs Presented by Partner Bristol Myers Squibb at AACR Annual Meeting

Ads

You May Also Like

Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance

Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform Collaboration leverages Ares Genetics’ ...

Sanionas spin-out Scandion Oncology får godkännande att noteras på Spotlight Stock Market

PRESSMEDDELANDE 1 oktober 2018 Saniona, ett ledande biomedicinbolag inom jonkanalsforskning, meddelade idag att deras ...

AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide

WALTHAM, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced ...